ArticleFrontiers in oncology2025
Identification of MAD2L1 as a novel biomarker for hepatoblastoma through bioinformatics and machine learning approaches.
Ying He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it